Legislative Research: NY S04513 | 2023-2024 | General Assembly

Other Sessions

SessionTitle/DescriptionLast Action
2023-2024
General Assembly

(Introduced)
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompe...
[S04513 2023 Detail][S04513 2023 Text][S04513 2023 Comments]
2024-05-15
REPORTED AND COMMITTED TO FINANCE
2021-2022
General Assembly

(Introduced - Dead)
Prohibits the assessment of fees for sales tax owed by small businesses during the COVID-19 state disaster emergency through 90 days after the end of such state disaster emergency.
[S04513 2021 Detail][S04513 2021 Text][S04513 2021 Comments]
2022-01-05
REFERRED TO INVESTIGATIONS AND GOVERNMENT OPERATIONS
2019-2020
General Assembly

(Introduced - Dead)
Makes it unlawful for an employer to fail to take immediate and appropriate corrective action when he or she knows of a non-employee sexually harassing certain employees.
[S04513 2019 Detail][S04513 2019 Text][S04513 2019 Comments]
2020-01-08
REFERRED TO INVESTIGATIONS AND GOVERNMENT OPERATIONS
2017-2018
General Assembly

(Introduced - Dead)
Relates to reports on untested sexual offense evidence collection kits; requires law enforcement agencies to report to the division of criminal justice services on the number of tested and untested sexual offense evidence collection kits; requires th...
[S04513 2017 Detail][S04513 2017 Text][S04513 2017 Comments]
2018-01-03
REFERRED TO FINANCE
2015-2016
General Assembly

(Engrossed - Dead)
Authorizes and directs the commissioner of education to develop guidelines for transportation of students on field trips.
[S04513 2015 Detail][S04513 2015 Text][S04513 2015 Comments]
2016-06-07
referred to education
2013-2014
General Assembly

(Introduced - Dead)
Requires transporters, school districts, and counties to establish a rider verification system for certain special transportation passengers.
[S04513 2013 Detail][S04513 2013 Text][S04513 2013 Comments]
2014-01-08
REFERRED TO EDUCATION
2011-2012
General Assembly

(Introduced - Dead)
Provides that there shall be no duty to keep premises safe for entry or use by others for recreational aviation activities.
[S04513 2011 Detail][S04513 2011 Text][S04513 2011 Comments]
2012-01-04
REFERRED TO JUDICIARY
2009-2010
General Assembly

(Introduced - Dead)
Requires day care providers to escrow security deposits in excess of the value of two weeks of provided services.
[S04513 2009 Detail][S04513 2009 Text][S04513 2009 Comments]
2010-01-06
REFERRED TO CHILDREN AND FAMILIES

References Online

Search PhraseWebNewsFinancialEncylopediaBiography
[New York S04513]Google WebGoogle News
[New York Senate Finance Committee]Google WebGoogle NewsN/A
[Senator Nathalia Fernandez NY]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart
[Senator Samra Brouk NY]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart
[Senator Rachel May NY]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart
[Senator Lea Webb NY]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart

Legislative Citation

APA
NY S04513 | 2023-2024 | General Assembly. (2024, May 15). LegiScan. Retrieved December 25, 2024, from https://legiscan.com/NY/bill/S04513/2023
MLA
"NY S04513 | 2023-2024 | General Assembly." LegiScan. LegiScan LLC, 15 May. 2024. Web. 25 Dec. 2024. <https://legiscan.com/NY/bill/S04513/2023>.
Chicago
"NY S04513 | 2023-2024 | General Assembly." May 15, 2024 LegiScan. Accessed December 25, 2024. https://legiscan.com/NY/bill/S04513/2023.
Turabian
LegiScan. NY S04513 | 2023-2024 | General Assembly. 15 May 2024. https://legiscan.com/NY/bill/S04513/2023 (accessed December 25, 2024).

Same As/Similar To

BillRelationshipDateTitleLast Action
A07465Same As2024-01-03Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.referred to health

New York State Sources


feedback